Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway
- 8 July 2008
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 32 (1) , 116-124
- https://doi.org/10.1016/j.nbd.2008.06.016
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Molecular biology changes associated with LRRK2 mutations in Parkinson's diseaseJournal of Neuroscience Research, 2008
- Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative diseasePharmacology & Therapeutics, 2007
- Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicityHuman Molecular Genetics, 2007
- Clinicogenetic study of mutations inLRRK2 exon 41 in Parkinson's disease patients from 18 countriesMovement Disorders, 2006
- Coordinating ERK/MAPK signalling through scaffolds and inhibitorsNature Reviews Molecular Cell Biology, 2005
- Molecular genetic pathways in Parkinson's disease: a reviewClinical Science, 2005
- Analysis of LRRK2 G2019S and I2020T mutations in Parkinson's diseaseNeuroscience Letters, 2005
- Activated mitogen-activated protein kinase kinase 7 redistributes to the cytosol and binds to Jun N-terminal kinase-interacting protein 1 involving oxidative stress during early reperfusion in rat hippocampal CA1 regionJournal of Neurochemistry, 2005
- Docking Interactions in the c-Jun N-terminal Kinase PathwayJournal of Biological Chemistry, 2004
- Inhibition of JNK by Overexpression of the JNK Binding Domain of JIP-1 Prevents Apoptosis in Sympathetic NeuronsPublished by Elsevier ,2001